Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
IDH1 mutation
Cancer:
Astrocytoma
Regimen:
(lomustine + Matulane (procarbazine hydrochloride) + vincristine)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
ADULT GLIOMA: IDH-MUTANT ASTROCYTOMA...Adjuvant Treatment WHO grade 2, KPS ≥60….Preferred Regimens...RT + adjuvant PCV (category 1)...Other Recommended Regimens...PCV
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login